FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

79605009: 3 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    132068015 Three en Synonym Active Entire term case insensitive SNOMED CT core module
    820674014 Three (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442100016 3 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442101017 3 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    3 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    3 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely flupentixol (as flupentixol hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and methscopolamine and pseudoephedrine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and phenylephrine and phenyltoloxamine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and phenylephrine and phenyltoloxamine in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely tobramycin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing only amlodipine and hydrochlorothiazide and olmesartan in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely tobramycin 3 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing only caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely dexamethasone 500 microgram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely adapalene 3 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely ethinylestradiol 20 microgram and ferrous fumarate 75 milligram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 3
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely dextromethorphan hydrobromide 3 milligram/1 milliliter and promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and guaifenesin 40 milligram/1 milliliter and hydrocodone bitartrate 1 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 3
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine 800 microgram/1 milliliter and dextromethorphan 3 milligram/1 milliliter and pseudoephedrine 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and codeine phosphate 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely brompheniramine 800 microgram/1 milliliter and dextromethorphan 6 milligram/1 milliliter and pseudoephedrine 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 2 milligram/1 milliliter and phenylephrine hydrochloride 1 milligram/1 milliliter and promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1

    Start Previous Page 4 of 6 Next End

    This concept is not in any reference sets

    Back to Start